This call is for bold, innovative research that has the potential to impact the way prostate cancer is diagnosed, treated or prevented. This scheme will fund fundamental and clinical research, and all stages in between; however, research at all stages will be expected to have a focus on eventual benefit to men. Applicants will be expected to set out a logical and realistic path of work that will need to happen at the end of the award in order to deliver that benefit to men.
We will also consider applications that bring innovative ideas from other cancer types and other diseases to be tested or translated for prostate cancer. We encourage applicants to build teams that include experts from other disciplines and other countries where that will improve the project.
All proposals must align with our research strategy and clearly demonstrate the innovative nature of the research and how it will lead to improved health and well-being for men affected by, or at high risk of, prostate cancer.
There is a two-stage application process whereby applicants initially submit an Expression of Interest and if shortlisted, are requested to submit a more detailed Second Stage application. Applicants should ensure they download and carefully read the guidance notes before submitting their proposal.2018 RIA EOI Guidance 2018 RIA Stage 2 Guidance
1: Expression of Interest (EOI) Stage
2: Second Stage (for shortlisted applicants)
Once the final funding decisions have been confirmed, applicants will be informed of the outcome by email in May 2019.
You can view our current and previously funded Research Innovation Awards here.
If you have any questions or would like to discuss an application with the Research team, please e-mail email@example.com or call 020 3310 7258.